5867.0000 68.00 (1.17%)
NSE Jan 12, 2026 15:31 PM
Volume: 118.2K
 

5867.00
1.17%
ICICI Securities Limited
Alkem Laboratories’ (Alkem) Q1FY23 performance was lower than our estimates on the profitability front. Revenue declined 5.7% YoY to Rs 25.8bn (I-Sec: Rs 24.9bn) on a high base due to covid.
Alkem Laboratories Ltd. is trading above all available SMAs
More from Alkem Laboratories Ltd.
Recommended